JP2013534537A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013534537A5 JP2013534537A5 JP2013519757A JP2013519757A JP2013534537A5 JP 2013534537 A5 JP2013534537 A5 JP 2013534537A5 JP 2013519757 A JP2013519757 A JP 2013519757A JP 2013519757 A JP2013519757 A JP 2013519757A JP 2013534537 A5 JP2013534537 A5 JP 2013534537A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- patent application
- application publication
- international
- document
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZHSKUOZOLHMKEA-UHFFFAOYSA-N 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydron;chloride Chemical compound Cl.ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 ZHSKUOZOLHMKEA-UHFFFAOYSA-N 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- YTKUWDBFDASYHO-UHFFFAOYSA-N bendamustine Chemical compound ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 YTKUWDBFDASYHO-UHFFFAOYSA-N 0.000 description 1
- 229960002707 bendamustine Drugs 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36384710P | 2010-07-13 | 2010-07-13 | |
| US61/363,847 | 2010-07-13 | ||
| PCT/US2011/043614 WO2012009299A1 (en) | 2010-07-13 | 2011-07-12 | Improved methods for the sterilization of bendamustine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013534537A JP2013534537A (ja) | 2013-09-05 |
| JP2013534537A5 true JP2013534537A5 (https=) | 2015-03-12 |
Family
ID=44510172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013519757A Pending JP2013534537A (ja) | 2010-07-13 | 2011-07-12 | ベンダムスチンの殺菌における改良された方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130144068A1 (https=) |
| EP (1) | EP2593144A1 (https=) |
| JP (1) | JP2013534537A (https=) |
| CN (1) | CN103052407A (https=) |
| AU (1) | AU2011279402A1 (https=) |
| CA (1) | CA2804865A1 (https=) |
| MX (1) | MX2013000373A (https=) |
| WO (1) | WO2012009299A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375965B (zh) * | 2017-07-18 | 2019-02-15 | 江门华大生物科技有限公司 | 中药饮片无硫杀虫保藏方法 |
| KR102086318B1 (ko) * | 2018-03-12 | 2020-03-09 | 주식회사 코스메카코리아 | 감마선 조사를 통한 유연성을 가지는 고형의 경시적 색변화 하이드로겔 화장료 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422068A (en) * | 1994-01-05 | 1995-06-06 | Shalaby; Shalaby W. | Radiochemical sterilization |
| CN2225245Y (zh) * | 1995-06-20 | 1996-04-24 | 鞍山钢铁公司 | 快速微型固体干热消毒装置 |
| US6632648B1 (en) * | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| CN101366954B (zh) * | 2008-09-19 | 2013-03-20 | 乐普（北京）医疗器械股份有限公司 | 一种生物涂层医疗装置的灭菌处理方法 |
| EP2346836B1 (en) * | 2008-10-08 | 2018-03-07 | Cephalon, Inc. | Processes for the preparation of bendamustine |
-
2011
- 2011-07-12 MX MX2013000373A patent/MX2013000373A/es not_active Application Discontinuation
- 2011-07-12 JP JP2013519757A patent/JP2013534537A/ja active Pending
- 2011-07-12 AU AU2011279402A patent/AU2011279402A1/en not_active Abandoned
- 2011-07-12 CN CN2011800345139A patent/CN103052407A/zh active Pending
- 2011-07-12 WO PCT/US2011/043614 patent/WO2012009299A1/en not_active Ceased
- 2011-07-12 CA CA2804865A patent/CA2804865A1/en not_active Abandoned
- 2011-07-12 EP EP11738541.9A patent/EP2593144A1/en not_active Withdrawn
-
2013
- 2013-01-09 US US13/737,213 patent/US20130144068A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| JP2012500004A5 (https=) | ||
| PH12014502835A1 (en) | Preparation, uses and solid forms of obeticholic acid | |
| CL2013001340A1 (es) | Compuestos derivados de isoindol-amida, pirrolo-piridin-amida y pirrolo-pirimimidin-amida, inhibidores de nampt y rock; composicion farmaceutica; y metodo para tratar hiperetension, insuficiencia cardiaca cronica, aterosclerosis, asma, enfermedad de alzheimer, enfermedad de parkinson y glaucoma, entre otras enfermedades. | |
| BR112014009910A2 (pt) | formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico | |
| JO3754B1 (ar) | أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون | |
| JP2013517798A5 (https=) | ||
| EA201270561A1 (ru) | Антагонисты рецептора cgrp | |
| JP2011037901A5 (https=) | ||
| UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
| JP2011057670A5 (https=) | ||
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| BR112014006220A2 (pt) | composições de galacto-ramnogalacturonato para o tratamento de esteatohepatite não alcoólica e de doença de gordura no fígado não alcoólica | |
| MX2009009592A (es) | Aminopiridinas utiles como inhibidores de proteinas cinasas. | |
| JP2016540749A5 (https=) | ||
| AU2011286276A8 (en) | Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases | |
| JP2014519854A5 (https=) | ||
| BR112014010401A8 (pt) | Inibidores do vírus da hepatite c rod-like que contêm o fragmento {2-[4-(bifenil-4-il)-1h-imidazo-2-il] pirrolidina-1-carbonilmetil}amina | |
| BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
| EA201290552A1 (ru) | Способ производства фармацевтически активного вещества | |
| PH12016500042A1 (en) | Stabilized pharmaceutical dosage forms comprising atrasentan | |
| EA201500575A1 (ru) | Транс-4-{2-[4-(2,3-дихлорфенил)пиперазин-1-ил]этил}-n,n-диметилкарбамоилциклогексиламин для лечения негативных симптомов шизофрении | |
| TN2012000431A1 (en) | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |